Metabolites as novel biomarkers for childhood obesity-related traits in Mexican-American children

Pediatric Obesity

Volumn 10, Issue 4, 2015, Pages 320-327

  Farook, V S ^a   Reddivari, L ^b   Chittoor, G ^a   Puppala, S ^a   Arya, R ^c   Fowler, S P ^c   Hunt, K J ^d   Curran, J E ^a   Comuzzie, A G ^a   Lehman, D M ^c   Jenkinson, C P ^c   Lynch, J L ^c   Defronzo, R A ^c   Blangero, J ^a   Hale, D E ^c   Duggirala, R ^a   Vanamala, J ^b  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Biomarkers; childhood obesity; metabolites; Mexican Americans

Indexed keywords

2 METHYLBUTYROYLCARNITINE; 3 HYDROXYQUININE; BIOLOGICAL MARKER; BRADYKININ; CALICOFEROL B; CARNITINE DERIVATIVE; COLECALCIFEROL; DIACYLGLYCEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROQUININE; INDOLEPROPIONIC ACID; LINOLEIC ACID; LYSOPHOSPHATIDYLCHOLINE; MALVIDIN 3 (6 ACETYL GLUCOSIDE); NARINGENIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHORYLCHOLINE; THYRONINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VITAMIN; C REACTIVE PROTEIN; CYTOKINE; INSULIN; INTERLEUKIN 6; LEPTIN; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; BODY MASS; BODY WEIGHT; CARDIOMETABOLIC RISK; CHILD; CHILDHOOD OBESITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; METABOLITE; MEXICAN AMERICAN; PILOT STUDY; PRIORITY JOURNAL; QUADRUPLE ORTHOGONAL ACCELERATION TIME OF FLIGHT TANDEM MICRO MASS SPECTROMETRY; SCREENING; SYSTOLIC BLOOD PRESSURE; TIME OF FLIGHT MASS SPECTROMETRY; TREND STUDY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WAIST CIRCUMFERENCE; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; METABOLISM; PEDIATRIC OBESITY; REFERENCE VALUE; RISK FACTOR; UNITED STATES;

ADOLESCENT; BIOMARKERS; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CHILD; CHOLESTEROL, HDL; CYTOKINES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LEPTIN; LIPIDS; MALE; MEXICAN AMERICANS; PEDIATRIC OBESITY; REFERENCE VALUES; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES; WAIST CIRCUMFERENCE;

EID: 84988281658     PISSN: 20476302     EISSN: 20476310     Source Type: Journal    
DOI: 10.1111/ijpo.270     Document Type: Article

References (31)

1. Ogden CL, Flegal KM, Carroll MD, Johnson CL,. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002; 288: 1728-1732.
2. Ogden CL, Carroll MD, Kit BK, Flegal KM,. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012; 307: 483-490.
3. Schusterova I, Leenen FH, Jurko A, Sabol F, Takacova J,. Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents. Pediatr Obes 2014; 9: 63-70.
4. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH,. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-1529.
5. Tobisch B, Blatniczky L, Barkai L,. Cardiometabolic risk factors and insulin resistance in obese children and adolescents: relation to puberty. Pediatr Obes 2013; doi: 10.1111/j.2047-6310.2013.00202.x. [Epub 2013/11/15].
6. DeBoer MD,. Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention. Expert Rev Endocrinol Metab 2011; 6: 279-289.
7. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML,. Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009; 119: 628-647.
8. Kussmann M, Raymond F, Affolter M,. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol 2006; 124: 758-787.
9. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9: 311-326.
10. Kim JY, Park JY, Kim OY, et al. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J Proteome Res 2010; 9: 4368-4375.
11. Oberbach A, Blüher M, Wirth H, et al. Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. J Proteome Res 2011; 10: 4769-4788.
12. Fowler SP, Puppala S, Arya R, et al. Genetic epidemiologic investigation of metabolic syndrome in Mexican American children and adolescents: the SAFARI study. Hum Genet 2013; 132: 1059-1071.
13. Wahl S, Yu Z, Kleber M, et al. Childhood obesity is associated with changes in the serum metabolite profile. Obes Facts 2012; 5: 660-670.
14. Oppenheimer JH, Schwartz HL, Lane JT, Thompson MP,. Functional relationship of thyroid hormone induced lipogenesis, lipolysis, and thermogenesis in the rat. J Clin Invest 1991; 87: 125-132.
15. Lanni A, Moreno M, Lombardi A, et al. 3,5-Diiodo-l-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB J 2005; 19: 1552-1554.
16. Weinstein SP, Watts J, Haber RS,. Thyroid hormone increases muscle/fat glucose transporter gene expression in rat skeletal muscle. Endocrinology 1991; 129: 455-464.
17. Weinstein SP, O'Boyle E, Haber RS,. Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle. The role of GLUT4 glucose transporter expression. Diabetes 1994; 43: 1185-1189.
18. Dimitriadis G, Parry-Billings M, Bevan S, et al. The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clin Invest 1997; 27: 475-483.
19. Proud D, Kaplan AP,. Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol 1988; 6: 49-83.
20. Colman RW, Schmaier AH,. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 1997; 90: 3819-3843.
21. Dendorfer A, Wolfrum S, Dominiak P,. Pharmacology and cardiovascular implications of the kinin-kallikrein system. Jpn J Pharmacol 1999; 79: 403-426.
22. Weil BR, Stauffer BL, Mestek ML, DeSouza CA,. Influence of abdominal obesity on vascular endothelial function in overweight/obese adult men. Obesity (Silver Spring) 2011; 19: 1742-1746.
23. Peng ZY, Zhao SP, He BM, Peng DQ, Hu M,. Protective effect of HDL on endothelial NO production: the role of DDAH/ADMA pathway. Mol Cell Biochem 2011; 351: 243-249.
24. Miyata T, Taguchi T, Uehara M, et al. Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts. Eur J Endocrinol 1998; 138: 344-352.
25. Pretorius M, Brown NJ,. Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release. J Pharmacol Exp Ther 2010; 2010: 291-297.
26. Iozzo P, Viljanen A, Guzzardi MA, Laine H, Honka MJ, Ferrannini E, Nuutila P,. The interaction of blood flow, insulin, and bradykinin in regulating glucose uptake in lower-body adipose tissue in lean and obese subjects. J Clin Endocrinol Metab 2012; 97: E1192-E1196.
27. Xia X, Weng J,. Targeting metabolic syndrome: candidate natural agents. J Diabetes 2010; 2: 243-249.
28. Ha CY, Kim JY, Paik JK, Kim OY, Paik YH, Lee EJ, Lee JH,. The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes. Clin Endocrinol (Oxf) 2012; 76: 674-682.
29. Alexander D, Lombardi R, Rodriguez G, Mitchell MM, Marian AJ,. Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy. Eur J Clin Invest 2011; 41: 527-538.
30. Sjoberg BG, Su J, Dahlbom I, et al. Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men. Atherosclerosis 2009; 203: 528-532.
31. Kabadi SM, Lee BK, Liu L,. Joint effects of obesity and vitamin d insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001-2006. Diabetes Care 2012; 35: 2048-2054.